NYSE:VEEVHealthcare Services
Should Diverging Views On AI Risks And CRM Strengths Require Action From Veeva Systems (VEEV) Investors?
In recent months, several institutional investors highlighted Veeva Systems after strong recurring revenue growth and raised full-year guidance, even as its stock lagged amid a rotation away from higher-valuation healthcare technology names and caution around the timing of large enterprise deals.
While some funds exited Veeva citing rising competitive and AI-related risks, others emphasized its leading life sciences CRM platform and expanding role across R&D and commercial data clouds,...